← Back to Search

Participants with emergent large vessel occlusion undegoing intracranial mechanical thromebctomy for Stroke (MINT Trial)

N/A
Recruiting
Led By Kaustubh Limaye, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18-85 years Time of onset < 24 hours Acute stroke patient with NIHSS >6 CT-ASPECTS ≥ 6 Proven intracranial occlusion - (ICA-T, M1) Modified Rankin score: 0-2
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure duration
Awards & highlights

MINT Trial Summary

The aim of this study is to develop a multicenter database of patient data and outcomes for patients undergoing intracranial thrombectomy for acute ischemic stroke secondary to emergent large vessel occlusion with delivery of reperfusion catheter over a novel macrowire (Aristotle Colossus) to perform intracranial mechanical thrombectomy.

Eligible Conditions
  • Stroke

MINT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MINT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraprocedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraprocedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ability to deliver reperfusion catheter to the intracranial occlusion with macrowire alone (Yes/No)
Secondary outcome measures
Time from vascular access to first intracranial pass (minutes)
Time from vascular access to recanalization (minutes)
Vessel dissection (Yes/No)

MINT Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with emergent large vessel occlusion undegoing intracranial mechanical thromebctomyExperimental Treatment1 Intervention
Participants with emergent large vessel occlusion undergoing intracranial mechanical thrombectomy where the reperfusion catheter was delivered over a macrowire to perform thrombectomy.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,782 Total Patients Enrolled
13 Trials studying Stroke
3,862 Patients Enrolled for Stroke
Kaustubh Limaye, MDPrincipal InvestigatorIndiana University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
New England Journal of MedicineJournal
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Goyal, Mayank, Andrew M. Demchuk, Bijoy K. Menon, Muneer Eesa, Jeremy L. Rempel, John Thornton, Daniel Roy, et al.. 2015. “Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa1414905.
clinicaltrials.govStudy
Macrowire for IntracraNial Thrombectomy
Kaustubh Limaye 2023. "Macrowire for IntracraNial Thrombectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06148675.
All > Indianapolis
~104 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top